Full-Time

Senior Oracle Cloud SCM Applications Developer

ZOLL Medical Corporation

ZOLL Medical Corporation

1,001-5,000 employees

Cardiac resuscitation devices with integrated software

Compensation Overview

$123k - $145k/yr

+ Bonus

No H1B Sponsorship

Madison, WI, USA + 2 more

More locations: Lowell, MA, USA | Central Falls, RI, USA

In Person

Category
Software Engineering (1)
Required Skills
Agile
SQL
Salesforce
REST APIs
Requirements
  • Bachelor degree in Computer Science or a related field is required.
  • Minimum 3-year implementation experience in Oracle Cloud Software as a Service Supply Chain Management (SCM) and 5-years solid technology-functional experience in Oracle E-Business Release 12/11i implementation focusing on SCM modules.
  • Experience with B2B, B2C Commerce, EDI, 3PL Integrations.
  • Proven abilities in translating business requirements into system solutions.
  • Excellent technical knowledge of Oracle SCM modules.
  • Extensive experience with global cross-functional teams in at least 3 full life-cycle Oracle Cloud SaaS, R12/11i implementations.
  • Working knowledge of Oracle Cloud development using Oracle Integration Cloud, Visual Builder Studio, APEX, Fusion Middleware Design Language (FBDL), or BI Analytics reports.
  • In-depth knowledge of Oracle APIs as well as Oracle Integration Cloud, REST/SOAP web services.
  • Experience in Design and Development of Workflows and Adaptive Messaging Environment (AME).
  • Extensive knowledge of SQL, PL/SQL, Oracle Applications Framework (OAF) skills including performance tuning.
  • Experience with Oracle XML Reports.
  • Knowledge of Oracle Cloud Analytics.
  • Familiar with Agile methodology, ITIL framework, and Software Development Life Cycle process.
  • Strong analytical and problem-solving skills.
  • Strong Communication skills.
  • Effective team player.
Responsibilities
  • Participate in and contribute to Oracle Cloud Implementation project globally.
  • Work closely with Oracle Supply Chain Manager, Business Systems Analyst (BSA) and business users to develop Oracle Cloud Integrations, Extensions, and Reports that meet business requirements.
  • Prepare technical design based on business requirement and functional design.
  • Develop WRICE components using Oracle Integration Cloud, Visual Builder Studio, REST API, EDI, JSON, and other related tools in Plan to Make, Order to Cash, Procure to Pay, and Logistics functional areas.
  • Prepare test scripts and perform unit test, and Integration Test.
  • Participate in all phases of Oracle Cloud implementations.
  • Provide production enhancement using Oracle E-Business Suite development tools, such as SQL, PL/SQL, XML Publisher, Workflow Builder, etc.
  • Provide daily support for Oracle production issues.
  • Provide expertise for IT projects and Oracle implementation support across ZOLL business sites globally.
  • Provide technical support to Sales and Operations business users for various related tools and integrations.
  • Re-engineer existing business system processes to leverage the capabilities of both the Oracle Cloud Software as a Service and Platform as a Service applications.
Desired Qualifications
  • Oracle Certificate in Oracle PaaS (OIC, VBCS) will be a plus
ZOLL Medical Corporation

ZOLL Medical Corporation

View

ZOLL Medical Corporation designs and sells medical devices and software for emergency and critical care. Its products include defibrillators and AEDs, mobile ECG systems, disposable electrodes, temperature management devices, sleep apnea solutions, and software that integrates with hardware to manage patient data. It differentiates itself by offering an integrated hardware-software ecosystem focused on cardiac resuscitation and critical care with a global reach to hospitals and EMS. Its goal is to improve patient outcomes and clinical and operational efficiency through end-to-end, data-enabled emergency and critical care solutions.

Company Size

1,001-5,000

Company Stage

Acquired

Total Funding

$2.2B

Headquarters

Chelmsford, Massachusetts

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Eric Knudsen's CEO appointment drives growth from 30 years medtech expertise.
  • ZOLL Itamar achieves profitability surge under Knudsen's prior leadership.
  • EU MDR approval expands Zenix sales in Europe for hospitals and EMS.

What critics are saying

  • Medtronic LifePak captures 45% US EMS share, eroding X Series sales.
  • Stryker LUCAS 4 beats AutoPulse NXT by 18% ROSC in 2025 AHA trials.
  • ResMed NightOwl halves ZOLL Itamar's $200M sleep diagnostics revenue.

What makes ZOLL Medical Corporation unique

  • Zenix defibrillator offers Real CPR Help and touchscreen customization for EMS.
  • TherOx SSO2 Therapy gains Vizient contract for post-heart attack oxygen delivery.
  • AutoPulse NXT deployed nationwide by Air Methods for air medical transports.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Casual Work Environment

Company News

Business Wire
Feb 10th, 2026
ZOLL's Zenix monitor/defibrillator receives EU MDR approval for EMS and hospital use

ZOLL, an Asahi Kasei company manufacturing medical devices, has announced that its Zenix monitor/defibrillator received approval under the European Union Medical Device Regulation 2017/745. The device is designed for use in both emergency medical services and hospital settings. Zenix features a large touchscreen and on-the-fly customisation capabilities, allowing healthcare professionals to make real-time adjustments during critical situations. The device incorporates ZOLL's Real BVM Help and Real CPR Help technology, providing clinical feedback to improve ventilation quality and CPR delivery. According to Elijah White, president of ZOLL Acute Care Technology, virtually all device functions are accessible with three screen-touches or fewer. Zenix joins ZOLL's existing portfolio of professional monitors and defibrillators, including the X Series, R Series and M2 models.

The AI Journal Ltd
Feb 4th, 2026
ZOLL Medical Appoints Eric Knudsen as New CEO

ZOLL medical appoints Eric Knudsen as new CEO. CHELMSFORD, Mass. - (BUSINESS WIRE) - ZOLL(R), an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that it has appointed Eric Knudsen as its new Chief Executive Officer, effective April 1. Knudsen will succeed Jon Rennert, who served as ZOLL's CEO for the past 10 years and will assume a new role as Executive Chairman of ZOLL's Board of Directors. "As a global leader in medical technology, ZOLL is continually looking for ways to expand our business and reach more patients in need," said Rennert. "Eric has played a unique role in developing our growth strategies and driving our expansion, and I am confident he will lead ZOLL to even greater growth and success." "I am honored to become ZOLL's next CEO," said Knudsen. "ZOLL has a long legacy of innovation and clinical excellence, and today our medical devices, software, and related services are used worldwide to diagnose and treat patients suffering from serious cardiopulmonary and respiratory conditions. We will continue to lead with our commitment to patients and customers and our passion for improving outcomes and helping save lives." Knudsen has nearly 30 years of experience in the medtech industry, with deep expertise in business development and corporate strategy. He led ZOLL's Corporate Development team for six years and was responsible for investing in strategic relationships and acquiring more than a dozen new technologies. For the past four years, Knudsen was President of ZOLL Itamar, a division of ZOLL that is focused on the diagnosis of sleep disorders. Knudsen led the division through significant growth and a dramatic increase in profitability. Prior to joining ZOLL in 2013, Knudsen held leadership positions in international sales, marketing, and manufacturing partnerships at Covidien (now Medtronic), Aspect Medical Systems, and LeMaitre Vascular. He has an MBA from the Thunderbird School of Global Management and a bachelor's degree from Boston College. Rennert was named CEO of ZOLL in 2016, after serving as President of the company's largest business unit for eight years. Under Rennert's leadership as CEO, ZOLL expanded its reach as a global leader in external defibrillation, pioneered novel solutions for patients with serious cardiopulmonary and respiratory conditions, and significantly broadened its portfolio of products. About ZOLL ZOLL, an Asahi Kasei company, develops and markets medical devices and software solutions that help advance care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and cardiac monitoring, circulation enhancement and CPR feedback, supersaturated oxygen therapy, data management, ventilation, therapeutic temperature management, and sleep apnea diagnosis and treatment, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, as well as lay rescuers, improve patient outcomes in critical cardiopulmonary conditions. For more information, visit www.zoll.com. About Asahi Kasei The Asahi Kasei Group contributes to life and living for people around the world. Since its foundation in 1922 with ammonia and cellulose fiber businesses, Asahi Kasei has consistently grown through the proactive transformation of its business portfolio to meet the evolving needs of every age. With 50,000 employees worldwide, the company contributes to a sustainable society by providing solutions to the world's challenges through its three business sectors of Healthcare, Homes, and Material. Its healthcare operations include devices and systems for critical care, products and services for the manufacture of biotherapeutics, and a growing portfolio of specialty pharmaceuticals. For more information, visit www.asahi-kasei.com. Asahi Kasei is also dedicated to sustainability initiatives and is contributing to reaching a carbon neutral society by 2050. To learn more, visit https://www.asahi-kasei.com/sustainability/. Matt Hogan ZOLL 978-805-6561 [email protected]

Air Methods
May 1st, 2025
Air Methods Enhances Patient Care and Safety with Nationwide Deployment of Zoll(R) AutoPulse(R) NXT

Air Methods collaborated closely with ZOLL to provide direct feedback during the development of the AutoPulse NXT, which was released in 2024.

ZOLL Data Systems
Aug 6th, 2024
Black Book Research Ranks ZOLL(R) AR Boost(R) as the #1 2024 Insurance Discovery Solution

The ZOLL AR Boost(R) Insurance Discovery tool secured the #1 spot in the 2024 Insurance Discovery Solutions category.

Law360
Apr 12th, 2024
Zoll Says 'Cookie-Cutter' Hack Claims Don't Show Harm

Zoll Medical Corp. is asking a Boston federal judge to toss a proposed class action brought by medical device customers whose personal information was released during a ransomware attack last year...